Barclays’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,000
| Closed | -$3.56M | – | 5662 |
|
|
2025
Q1 | $3.56M | Hold |
27,000
| – | – | ﹤0.01% | 2184 |
|
|
2024
Q4 | $2.26M | Buy |
+27,000
| New | +$2.22M | ﹤0.01% | 2790 |
|
|
2020
Q3 | – | Sell |
-3,700
| Closed | -$95K | – | 5679 |
|
|
2020
Q2 | $95K | Buy |
+3,700
| New | +$74.9K | ﹤0.01% | 4557 |
|
|
2019
Q3 | – | Sell |
-32,900
| Closed | -$427K | – | 7226 |
|
|
2019
Q2 | $427K | Buy |
+32,900
| New | +$422K | ﹤0.01% | 4466 |
|
|
2019
Q1 | – | Sell |
-6,500
| Closed | -$74K | – | 7406 |
|
|
2018
Q4 | $74K | Buy |
+6,500
| New | +$105K | ﹤0.01% | 5247 |
|
|
2018
Q1 | – | Sell |
-2,000
| Closed | -$29K | – | 7421 |
|
|
2017
Q4 | $29K | Buy |
+2,000
| New | +$30.9K | ﹤0.01% | 6102 |
|
|
2016
Q4 | – | Sell |
-180,000
| Closed | -$2.74M | – | 6904 |
|
|
2016
Q3 | $2.74M | Buy |
+180,000
| New | +$7.28M | 0.01% | 1736 |
|
|
2015
Q4 | – | Sell |
-185,700
| Closed | -$7.43M | – | 6700 |
|
|
2015
Q3 | $7.43M | Buy |
+185,700
| New | +$6.06M | 0.02% | 1111 |
|
Other funds holding ITCI
KIM
HNB